Jeff Yass’s Generate Biomedicines GENB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$683K Buy
45,445
+33,823
+291% +$520K ﹤0.01% 8927
2026
Q2
$196K Buy
+11,622
New +$158K ﹤0.01% 11973

Other funds holding GENB

Jeff Yass's GENB Position: Q3 2026 in Review

Jeff Yass increased its Generate Biomedicines (GENB) stake by 291% in Q3 2026, buying an estimated $520K and bringing the position to 45,445 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #8927.

Jeff Yass first reported a position in GENB in Q2 2026 and has held it in 2 quarters since. 107 funds tracked by Wall St. Rank hold GENB as of Q3 2026.

  • Jeff Yass held 45,445 shares of Generate Biomedicines worth $683K as of Q3 2026.
  • Jeff Yass bought 33,823 Generate Biomedicines shares in Q3 2026, an estimated $520K.
  • Generate Biomedicines made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #8927 holding.
  • Jeff Yass first reported a position in Generate Biomedicines in Q2 2026 and has held it in 2 quarters since.
  • 107 funds tracked by Wall St. Rank held Generate Biomedicines as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.